On the other hand, as observed in some GBM cell models, the catalytic degradation of vitamin D3 through the activation of CYP24A1 and CYP27B1 hampers the anti-tumoral effects of vitamin D3 and, hence, contributes to cell proliferation [30]. The gene discussed is CYP24A1; the disease is glioblastoma.